Phase I Study in China - Tolerability of a Single Dose of Abatacept 30 mg/kg

NCT00705367 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Lupus Nephritis

Interventions

DRUG: Placebo
DRUG: Abatacept
DRUG: Abatacept

Sponsor

Bristol-Myers Squibb